Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
CB1 receptor agonists
NE-CHMIMO
Другие языки:

    NE-CHMIMO

    Подписчиков: 0, рейтинг: 0
    NE-CHMIMO
    NE-CHMIMO.svg
    Legal status
    Legal status
    Identifiers
    • [1-(Cyclohexylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    Chemical and physical data
    Formula C26H25NO
    Molar mass 367.492 g·mol−1
    3D model (JSmol)
    • O=C(c1cccc2ccccc12)c3cn(CC4CCCCC4)c5ccccc35
    • InChI=1S/C26H25NO/c28-26(23-15-8-12-20-11-4-5-13-21(20)23)24-18-27(17-19-9-2-1-3-10-19)25-16-7-6-14-22(24)25/h4-8,11-16,18-19H,1-3,9-10,17H2
    • Key:HGJYPIZWMHHQKS-UHFFFAOYSA-N

    NE-CHMIMO (CHM-018) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation synthetic cannabinoid JWH-018. The corresponding cyclohexylmethyl derivative of JWH-081 had also been reported several months earlier.

    Legal status

    In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as NE-CHMIMO are Schedule I Controlled Substances.

    NE-CHMIMO is a controlled substance in Japan as of November 2019.

    See also


    Новое сообщение